Toubai T, Tanaka J, Kobayashi N, Honda T, Miura Y, Ogawa T, Imai K, Ogasawara M, Kiyama Y, Higa T, Imamura M, Kasai M
Department of Hematology, Sapporo Hokuyu Hospital, Japan.
Bone Marrow Transplant. 2004 Jun;33(11):1159-63. doi: 10.1038/sj.bmt.1704491.
It is difficult to treat lung complications caused by chronic graft-versus-host disease (GVHD) after allogeneic stem cell transplantation (allo-SCT). We retrospectively analyzed the characteristics of five patients with mediastinal emphysema (ME) and bilateral pneumothoraces (BP) caused by chronic lung GVHD after allo-SCT. Four of these patients had undergone unrelated SCT, and three had had HLA-identical unrelated donors. All patients received total body irradiation (TBI) during conditioning. Immunosuppressive agents were administered as GHVD prophylaxis, but two patients developed acute GVHD and all the five developed chronic GVHD. The onset of lung complications was 99-1915 days (median, 202 days) after SCT. The onset of ME and BP was 6-48 days (median, 23 days) after the onset of lung complications. Immunosuppressive agents were initially beneficial on the lung complications, but the patients later showed no response to therapy, and all died from respiratory failure 7-195 days (median, 28 days) after the development of ME and BP. The results suggest that these complications progress rapidly, are resistant to treatment, and have a poor prognosis. It is therefore important to start prophylaxis and treatment as early as possible.
异基因干细胞移植(allo-SCT)后,慢性移植物抗宿主病(GVHD)所致肺部并发症难以治疗。我们回顾性分析了5例allo-SCT后因慢性肺部GVHD导致纵隔气肿(ME)和双侧气胸(BP)患者的特征。其中4例患者接受了非亲缘SCT,3例有HLA配型相合的非亲缘供者。所有患者在预处理期间均接受了全身照射(TBI)。给予免疫抑制剂预防GVHD,但2例患者发生了急性GVHD,5例均发生了慢性GVHD。肺部并发症发生于SCT后99 - 1915天(中位数为202天)。ME和BP发生于肺部并发症出现后6 - 48天(中位数为23天)。免疫抑制剂最初对肺部并发症有益,但患者后来对治疗无反应,所有患者在ME和BP出现后7 - 195天(中位数为28天)死于呼吸衰竭。结果表明,这些并发症进展迅速,治疗效果不佳,预后不良。因此,尽早开始预防和治疗非常重要。